Document Detail

Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea.
MedLine Citation:
PMID:  361068     Owner:  NLM     Status:  MEDLINE    
Fourteen women with normoprolactinaemic amenorrhoea were treated with bromocriptine (2.5 mg twice daily) for a period ranging from 4 to 17 weeks, while a matched group fo 19 amenorrhoeic women were treated with a placebo (one tablet twice daily) for 4 to 12 weeks. About half of the patients in both groups had at least one episode of vaginal bleeding during treatment. There was no clear difference in the menstrual and ovulatory pattern between placebo and bromocriptine groups.
P G Crosignani; E Reschini; G C Lombroso; M Arosio; M Peracchi
Related Documents :
7877518 - Acceptability and skin reactions to transdermal estrogen replacement therapy in relatio...
8416468 - Essential fatty acids in the treatment of premenstrual syndrome.
11137328 - Postmenopause hormone treatment in women with niddm or impaired glucose tolerance: the ...
8657828 - Double-blind, placebo-controlled, hormonal, syndromal and eeg mapping studies with tran...
25233808 - Association between serum 25-hydroxyvitamin d levels measured 24 hours after delivery ...
19245538 - Poly-l-lactic acid for hiv-1 facial lipoatrophy: 48-week follow-up.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  British journal of obstetrics and gynaecology     Volume:  85     ISSN:  0306-5456     ISO Abbreviation:  Br J Obstet Gynaecol     Publication Date:  1978 Oct 
Date Detail:
Created Date:  1979-01-26     Completed Date:  1979-01-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7503752     Medline TA:  Br J Obstet Gynaecol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  773-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amenorrhea / drug therapy*
Bromocriptine / therapeutic use*
Clinical Trials as Topic
Progesterone / blood
Prolactin / blood
Reg. No./Substance:
0/Placebos; 25614-03-3/Bromocriptine; 57-83-0/Progesterone; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A comparison of salbutamol and ethanol in the treatment of preterm labour.
Next Document:  Group B beta haemolytic streptococci in the female genital tract: a study of four clinic populations...